The purpose of this proficiency study was to assess the accuracy and consistency of blood lead level (BLLs) measurements in a study of Taiwanese adults. 
INTRODUCTION
Although a blood lead level is a good biomarker of lead absorption, variations of blood lead measurements exist within and between laboratories1-10~. The variations in measurement of blood lead levels (BLLs) may derive from random and systematic errors. A proficiency test program is applied to remove systematic error and to reduce the random error of measurements, especially in a multilaboratory study.
Requirements for accurate measurements of blood lead concentrations become more stringent as the baseline BLL of the general population declines.
Cases of lead poisoning due to occupational lead exposure and environmental pollution have been documented for more than 10 years in Taiwan". Measurement of blood lead concentrations was first introduced into Taiwan in the early 1980's, but a program to evaluate accuracy and consistency among laboratories was still lacking. A study was designed to measure the BLLs of Taiwanese adults in order to evaluate lead exposure through environmental sources12~. The validity and reliability of blood lead measurements of the participating laboratories were monitored in order to obtain accurate estimations of BLLs. This paper presents the performance of the six participating laboratories with comparison to the criteria for proficiency tests proposed by the U.S. Center for Disease Control and Prevention (CDC). Recently, a surveillance program was initiated in Taiwan to monitor occupational and environmental lead exposure in the population '3' 14) • This study provides a basis of quality control toward successful progress in the establishment of a reporting system.
MATERIALS AND METHODS
A total of 3,000 blood samples, collected from a random sample of Taiwanese adults, were distributed equally to the six participating laboratories for blood lead measurements.
These six laboratories are located in medical centers or medical schools where blood lead measurements have been routinely performed for several years. All of the laboratories use flameless atomic absorption spectrophotom-etry (AAS) and have similar protocols for blood lead measurements.
The proficiency test was conducted and supervised by a medical center laboratory which did not participate in the sample analysis.
This supervising laboratory had also participated in proficiency tests provided by the Quebec Center for Toxicology Interlaboratory Comparison program, Canada and the U.S. CDC. The laboratory technicians were trained in a workshop on blood lead measurement held three months before this study. An exercise of this proficiency test program was held from June to August. The formal running of this proficiency test began prior to (September to December) and continued through the period in which measurements of blood samples from Taiwanese adults were performed (January to May of the next year). A laboratory audit was held at the end of November in order to improve the internal quality control and the consistency of procedures in blood lead analysis.
Three quality control methods were used in this proficiency test program. First, certified whole blood controls (Kaulson Laboratories, Inc., New York), which included 11 blood lead concentrations ranging from 10 to 100 µg/dl, were selected for the accuracy test. Three randomly selected blood controls including low (10 to 22 µg/dl), medium (38 to 55 µg/dl), and high (79 to 100 µg/dl) target lead levels were mailed blindly to these 6 laboratories monthly from September to May. In order to identify the sample deterioration that may have occurred in the mailing process, the supervising laboratory concurrently measured the certified whole blood samples. The results of the measurements, including the laboratory records, readings of three tested blood samples and intralaboratory variations, were sent back to the supervising laboratory within two weeks. Any problem with an AAS machine or any change of technicians in this period was reported to the supervising laboratory.
Second, 10 blood samples from normal healthy donors were distributed blindly to the six laboratories for testing of interlaboratory variations during measurements of BLLs (March). None of these 10 donors had a known history of occupational lead exposure. All donors were nonsmokers with the exception of one individual who smoked 20 cigarettes per day for 20 years.
Third, 54 blood samples (nine samples from each laboratory) selected from the study population were blindly and repeatedly measured over two months (March and May) by the six laboratories to evaluate the intertime variations and intralaboratory consistency of blood lead measurements.
All of these whole blood samples were kept at -20°C. The pilot study showed that BLLs do not change over six months if blood samples are kept frozen at -20°C.
Statistical methods
The blood lead levels are presented as mean and standard deviations. Coefficients of variation (CVs) are used to present the variations among laboratories, time and testings. Paired t-test was used for comparison of repeated measurements.
RESULTS

Accuracy test of certified whole blood
Three blood samples at high, medium and low target lead values of certified whole blood controls were sent to these six laboratories as well as the supervising laboratory monthly. The mean BLLs measured by the six laboratories with comparison to the 11 certified target values are shown in Table 1 . The mean BLLs measured by the six laboratories were nearly within the criteria proposed by the CDC, U.S. Public Health Service6~, that is, ±4 µg/dl if blood lead value < 40 µg/dl and ±10% if value >_ 40 µg/dl. Although there was no systematic trend with time, most of the laboratories underestimated the true target values.
Since most of the BLLs in the nonexposed adults were less than 15 µg/dl, the certified blood controls at 10, 12, and 15 µg/dl target lead values were used to anaiyze the accuracy of the blood lead measurements among the six laboratories (Table 2) . Three blood controls at the target lead value of 10 µg/dl were measured at Fa mean of 9.2 µg/dl, four controls at 12 µg/dl were measured at a mean of 10.3 ` µg/dl, and four controls at 15 µg/dl were measured at a mean of 13.4 µg/ dl. The underestimations were 8%, 14% and 11%, respectively, at these three target lead values. The average of the underestimations was 11%. These results showed that there was an underestimation of 11% at BLLs less than 15 µg/dl. The underestimatian was 8% and 11% at the target values of 100 µg/dl and 95 µg/ dl, respectively (Table 1) . Consistency of measurements between laboratories was expressed as coefficients of variation (CVs). The CVs among 6 laboratories of the 11 target lead values are shown in Table 1 . The CVs in the first three months (September to November) were high, but declined to acceptable levels in the last 6 months. In the first 3 months, the CV for the low target value was as high as 37%, and the CVs for the medium and high target values were approximately 15%. A laboratory audit was held to improve the consensus of techniques.
In the last 6 months, the CVs decreased to between 12% and 22% at the low target values (10 to 22 µg/dl), between 9% and 16% at medium target values (38 to 55 µg/dl), and 7% at the high target values (100 µg/dl). In general, the CVs were higher at the low target lead values than at the medium and high values. However, the interlaboratory CVs in the last 6 months are considered to be acceptable with comparison to the CVs of other studies2, 6, s).
Precision test of interlaboratory variations Blood samples drawn from ten normal healthy donors without known history of lead exposure were sent blindly to the six laboratories in order to evaluate the interlaboratory variations.
The mean and standard deviations of blood lead levels measured by the six laboratories are shown in Table 3 . During this precision test, laboratory No. 3 reported that their AAS instrument was out of order and their results were excluded in the data analysis.
The standard deviations of the other five laboratories were less than 2µg/dl in 8 of 10 donors. Two donors were outside this range at 2.2 and 3.3 µg/dl. A standard deviation of less than 2 µg/ dl indicates that the interlaboratory variations meet the CDC criteria of ±4 µg/dl, which is equivalent to 2 standard deviations.
In addition, there was no statistical difference of mean BLLs measured by these five laboratories.
The only smoking donor (No. 3) showed the highest BLL in this study population, which was compatible with findings from our study and others12~. Precision test of intertime repeat measurements Fifty-four blood samples selected from the study population and measured by the six laboratories were blindly and repeatedly measured over two months in order to evaluate the intralaboratory and intertime variations.
The results of the baseline (pre-test) and repeat measurements of BLLs two months later (post-test) are shown in Table 4 . Eleven out of 54 blood samples showed discrepancies in the values of the repeat measurements.
However, most of the differences between the pretest and post-test levels were within the acceptable criteria of ±4 µg/dl. The mean BLL of the pre-test was 10.95 sg/dl, which was nearly the same as the mean BLL of the post-test (11.01 sg/dl). The mean difference between the pre-test and the post-test (0.06 µg/dl) was not statistically different by the paired t-test. These results reveal that variations exist in the repeat measurements, however, the means of the measurements are consistent over a two month period. The results imply that the time variations of the blood lead measurements may not affect the estimation of the mean BLL in Taiwanese adults. 
